Medical Services VScan HIV Test Kit Receives Approval in China

Article

EDMONTON, Alberta -- Medical Services International Inc. is pleased to announce that it has received full regulatory approval to sell its VScan HIV 1&2 rapid test kits in the Peoples Republic of China.  With the regulatory approval, the company will now begin processing the existing orders for the VScan HIV test kit that have an approximate value of $4,600,000 U.S.  These are initial orders and it is anticipated that additional orders will follow immediately.  The distribution network that has been established will begin its marketing program as quickly as it can be implemented.  The kits will be manufactured in the companys new Shanghai facility.  The company has agreed that the Shanghai facility will be the supplier for all of Southeast Asia.

With the regulatory approvals in China, India and Nigeria, plus other approvals that have been obtained in other countries, the VScan HIV1&2 rapid test kit is now approved for all levels including retail in countries representing approximately 40 percent of the world population.  These approvals are in countries that represent a significant proportion of the population worldwide that have severe HIV/AIDS problems.

Source: Medical Services International Inc.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.